23.7 C
Yaoundé
mercredi, novembre 30, 2022
Home Tags ViiV Healthcare Limited

Tag: ViiV Healthcare Limited

ViiV Healthcare, which is majority-owned by GlaxoSmithKline with Pfizer and Shionogi as shareholders, has filed an application with the FDA for a new formulation of the HIV pill Triumeq.
Can GlaxoSmithKline share price recover from a recent slump with the help of a new HIV drug and Covid-19 mRNA vaccine, or do analysts have a right to be bearish?
Can GlaxoSmithKline share price recover from a recent slump with the help of a new HIV drug and Covid-19 mRNA vaccine, or do analysts have a right to be bearish?
. ViiV Healthcare, la société mondiale de lutte contre le VIH, détenue majoritairement par GSK, a annoncé l'approbation de Vocabria (Cabo Injection - déc.. 12ème. 2020, 10h51)
. . Geneva, 30. November 2020  –   ViiV Healthcare, the global HIV specialty company, majority-owned by GlaxoSmithKline plc (“ GSK”), with Pfizer Inc. . and Shionogi Limited as shareholders, and the Medicines Patent Pool (MPP) announced today that it has signed a new voluntary license. . .
. . According to Dr. Noor Hisham Abdullah, General Director of Health, is the signing of a licensing agreement between the drug patent pool and ViiV Healthcare.
. . The agreement aims to expand access to Tivicay - an AIDS drug developed by ViiV Healthcare - in four countries.
The two-drug regimen continues to provide no inferior efficacy compared to a three-drug regimen
Ce site, comme beaucoup d’autres, utilise des petits fichiers appelés cookies pour nous aider à améliorer et personnaliser votre expérience.
Accepter
Privacy Policy